All News
All news
-
News Coming soon: Our New Headquarters
Our New Headquarters located at Dr.-Robert-Pfleger-Strasse in Bamberg, Germany -
News Our Sustainability Report 2019
Sustainability matters a great deal to everyone at Centrient Pharmaceuticals, it is core to our mission and essential in shaping our authentic and purposeful culture. Our promise of Sustainability means that we not only ‘do what we say’, but also we ar... -
News Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand -
News Marchesini Group Press Kit 2020
With a turnover of 441 million Euro in 2019 and 2,000 employees in Italy and abroad, Marchesini Group is a flagship of the Packaging Valley in Emilia Romagna and one of the top four worldwide manufacturers of automatic pharmaceutical and cosmetic packa... -
News New study further validates Bioiberica’s b-2Cool® native type II collagen as trusted source for holistic mobility solutions
New scientific research, published in Osteoarthritis and Cartilage, highlights the benefits of Bioiberica’s native (undenatured) type II collagen (b-2Cool®) in combination with other key ingredients for joint health: chondroitin sulphate, glucosamin... -
News Ingredients and Formulation - evolving opportunities and challenges
Ingredients are the lifeblood of the pharmaceutical and nutraceutical industries. They connect today’s cutting-edge medicine and consumer products makers with their origins in the chemicals sector of the late nineteenth century. While ingredients... -
News HK inno.N Corporation receives regulatory approval for first novel drug
Korean pharmaceutical firm HK inno.N Corp. said on Friday that its gastroesophageal reflux disease drug K-CAB has been approved by the Ministry of Food and Drug Safety, marking the first time for the company to launch an independently-developed novel d... -
News Usin Near-Infrared spectroscopy and chemometric modeling to simultaneously determine ibuprofen and caffeine concentration in softgels
Appearing in the September 2020 edition of Tablets & Capsules, this article summarizes a method for rapid and accurate determination of API concentration in the fill of soft gelatin capsules while little or no sample preparation. Applying chemometric m... -
News Xellia Pharmaceuticals Opens New Commercial Office in Dubai
Xellia Pharmaceuticals Opens New Commercial Office in Dubai -
News Samyang Biopharm USA, Inc and CanCure LLC Announce Global Strategic Collaboration to Advance Novel Immuno-Oncology Therapeutic
Samyang Biopharm USA, Inc. (https://us.samyangbiopharm.com) a global biotech subsidiary of the Samyang Pharmaceuticals Corp. (https://samyangbiopharm.com/eng), announced today that the company has entered into a worldwide licensing agreement with CanCu... -
News Samyang Biopharm USA in-licenses Talix Therapeutics’ first-in-class compound
Samyang Biopharm USA has licensed in Belgium’s Talix Therapeutics’ first-in-class immuno-oncology compound for global rights. -
News US biosimilars five years on: Life on Mars?
Richard Saynor on LinkedIn -
News New collaboration between Novartis and Africa Medical Supplies Platform
New collaboration between Novartis and Africa Medical Supplies Platform to facilitate supply of COVID-19 related medicines. Novartis and the African Union (AU) through the Africa Medical Supplies Platform (AMSP) have announced a new collaboration ... -
News Sandoz launches generic antibiotic Daptomycin in US
Sandoz Inc. announced the US market introduction of Daptomycin for injection 500 mg, an AP-rated generic version of Cubicin® (daptomycin)*, for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by Gram-p... -
News Bushu Pharma investing $100M to grow its footprint and services over the next five years
Bushu Pharma – a leading CDMO in Japan – is investing USD100 million over the next five years to expand its footprint and services, helping the company better respond to the requirements of its customers. -
News Daewoong to export gastric acid blocker to Mexico
Daewoong Pharmaceutical has signed a deal worth $50 million to supply Mexico’s Moksha8 with gastric acid blocker Fexuprazan. Given the local authorities' approval plan, Moksha8 aims to launch Fexuprazan in the second half of 2022. -
News Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker
- Selected as a Poster of Distinction for presentation during Digestive Disease Week 2020
- Proved its efficacy with outstanding inhibition of gastric acid secretion and safety
- Proactively targeting the anti-acid secretion agent market valu... -
News Daewoong signs an export contract for Fexuprazan - Provided to EMS (Brazil) for 10 years after local approval in Brazil
On the August 14th, Daewoong signed an export contract with EMS in Brazil for the P-CAB-affiliated gastric secretion inhibitor Fexuprazan. The contract amount is $72.58 million. EMS will be responsible for the local approval of Fexuprazan in Brazil. -
News Daewoong Pharmaceutical signs overseas researchers’ clinical trial agreement for COVID-19 treatment
- Cooperative relations related to global joint research for COVID-19 drug Camostat (Daewoong Brand: Foistar)
- Daewoong’s Foistar enters phase 2 clinical trials... Scheduled to proceed to phase 3 clinical trials by end of year -
News Daewoong Pharm’s COVID-19 cure enters Phase 2 trial in Mexico
An investigator-initiated Phase 2 clinical trial of Daewoong Pharm’s COVID-19 drug candidate has been kicked off at several health centers in Mexico, including Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. The sponsor-invest... -
News World's first zero carbon emission autoinjector from Ypsomed
Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The YpsoMate Zero is based on the proven YpsoMate autoinjector platform that offers convenient handling and patient safety. The new YpsoMate Zero uses alterna... -
News Introducing Bespak by Recipharm
In February 2020, Recipharm acquired Consort Medical plc, which included Bespak. The move was designed to strengthen Recipharm’s position as a leading inhalation company and one of the largest CDMOs in the world. -
News Remdesivir with Dexolve: fight against COVID-19
CycloLab, being involved in the fight, manufactures the critical excipient: sulfobutyl-ether-BCD (SBECD, Dexolve™) that enables Remdesivir to work. The unexpected and sudden outbreak along with the quick spread of the coronavirus-disease and rapid incr... -
News Alvotech and DKSH extend biosimilar partnership in Asia
The companies will commercialize six new biosimilar candidates addressing multiple therapeutic areas. -
News *Ultra Pure Sodium Hyaluronate* by Contipro
Please find company brochure attached that includes the ultra pure specification -
News Europital launches as a science-driven full-service CRO
Expanded CRO services to support biotechs and mid-sized pharma companies across trials in more than 40 countries. -
News Micreos initiates trial to evaluate world's first endolysin-drug as a therapy for atopic dermatitis
The targeted removal of one particular bacterial species from the skin microbiome, while preserving the beneficial ones, represents a new way to treat atopic dermatitis. -
News Tackling Issue of Pharmaceuticals in the Environment from Manufacturing Emissions
The second in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien -
News Pope Updated Pope 3L, 4L, 5L Benchtop Nutsche Filter Dryers Now Available
The latest Pope Benchtop Nutsche Filter Dryers are now available for quick delivery. -
News T-knife and Catalent sign tech transfer and manufacturing agreement
Catalent to manufacture clinical batches of T-knife's platform process for TCR-based cell therapy at its site in Gosselies, Belgium, for European trials in 2021. -
News Metrics Contract Services begins $10M plant expansion
Clients set to benefit immediately through "higher yields" and "improved potent handling". -
News TESSA technology for robust and reproducible AAV manufacture at scale
Novel, plasmid-free manufacturing system reduces the cost of goods and improves AAV quality to enable development of safer gene therapies. -
News Formulation development : Ongoing orphan drugs development projects
Several ongoing development programs are dedicated to the manufacturing of orphan drugs intended for both US and European patients. Skyepharma team is proud to work on orphan drugs development projects. -
News R&D: Collaborative thesis on the mechanical resistance of tab-in-tab tablets - Progress to date.
R&D : Mechanical resistance of pharmaceutical press coated tablets (tab-in-tab): characterization and link with material and process parameters. -
News Pipeline - Vildagliptin + Metformin Product Profile
Vildagliptin & Metformin(50+850 mg), (50+1000 mg) Film Coated Tablets Reference Product: Eucreas® / Novartis
-
News Pipeline - Ertapenem Product Profile
Ertapenem 1gPowder for concentrate for solution for infusion
Reference Product: Invanz® / MSD -
News Pipeline - Isavuconazole Product Profile
Isavuconazole 200mg Powder for concentrate for solution for infusion
Reference Product: Cresemba® / Basilea Pharmaceutica (Pfizer) -
News Pipeline - Brivaracetam Product Profile
Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
Reference Product: Briviact® / UCB -
News Pipeline - Lacosamide Product Profile
Lacosamide 10mg/ml (20ml Vial)Solution for Infusion
Reference Product: Vimpat® / UCB -
News New Formulation & Sterile-Fill Finish Facility Online Open House on Oct 9
We’re kicking off the opening of our new, 32,000 sq. ft formulation and sterile fill-fill finish facility with a digital open house on October 9 from 1:00-2:00 pm EDT. We have a range of technical experts as our speakers including Maria Lacou... -
News Meet our Solid State specialists
This month we launch our multi-million-pound Material Science Centre, home to our Solid State specialists, as well as our new milling, micronisation and solid state chemistry services. Here, the team introduce themselves and share a little more ab... -
News EMBO CAPS® by Suheung LP+ Liquid Capsule
Supplied globally under the Embocaps® by Suheung brand, the Embocaps® LP+ is a hard capsule specifically designed to hold liquids and fine powders. The Embocaps® LP+ is available in multiple gelatin, vegetarian and relayed release formulations. -
News EMBO CAPS ® by Suheung opens new capsule factory
Suheung Co., Ltd. today announces the opening of their new EMBO CAPS® VG-ALPHA capsule facility located in the Long Thanh Industrial Zone (Dong Nai Province), Vietnam. Exclusively a vegetarian capsule facility, the new factory will supply capsules... -
News EMBO CAPS® by Suheung receives China DMF Number for Gelatin
EmboCaps® by Suheung announces today that the China DMF filing for Empty Hard Gelatin Capsule(F20190000400) successfully completed on December 30, 2019 -
News EMBO CAPS® by Suheung receives China DMF Number for HPMC
Suheung Co., Ltd. announces today that the China DMF filing for it’s EMBOCAPS ® Empty Hard HPMC Capsules has been successfully submitted and received its DMF filing acceptance notice / Pre-assigned DMF Number F20190000399. -
News Getinge launches the DPTE® Transfer Trolley - safe, smart and simple
Getinge launches the DPTE® Transfer Trolley – a smart, mobile transfer platform for use with all standard DPTE® Beta solutions for moving materials into and out of a confined zone without breaking containment or sterility. Its ergonomic, ... -
News Serialization and aggregation in the pharmaceutical industry
The serialization system allows the verification of a drug's compliance from the distribution to the delivery then to the patient. This article explains the serialization and aggregation implemented at Skyepharma. -
News Skyepharma Analytical Services : Specialized teams
Skyepharma is a full CDMO. We have an analytical service that covers all aspects from development to manufacturing. Packaging, raw materials and finished products are all controlled by this service. -
News Skyepharma overcomes Russian serialisation complexities
Skyepharma has extended its serialisation and aggregation service to ‘hard to reach’ countries like Russia and Brazil. We are now able to offer serialized and aggregated supplies to Russia. -
News Supply Chain Reliability at Skyepharma, David Lescuyer's Interview
This article describes the robustness of Skyepharma's supply chain. The delivery of our products has not been impacted during this COVID-19 pandemic. Discover how! -
News Thermo Fisher Scientific Opens New Bioprocessing Collaboration Center in St. Louis
Thermo Fisher Scientific Inc., the world leader in serving science, announced the opening of its new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri. -
News The pharmaceutical sector in the Gulf Cooperation Council and the impact of COVID-19
Countries in the GCC have been concentrating their efforts to develop and grow their healthcare and pharmaceutical sectors as an integral part of a ten-year vision to diversify the region’s economy and reduce its dependency on crude oil. While th... -
News Gilead Sciences agrees to buy Immunomedics in $21 billion deal
Acquisition will add Trodelvy, a first-in-class antibody-drug conjugate approved to treat breast cancer. -
News Stevanato Group to open US Technology Excellence Center in Boston
Due to begin operations in late September, the US TEC will bring value-added laboratory services to the heart of the biotech community. -
News Dexamethasone sodium phosphate in syrup
Discover our new Dexamethasone sodium phosphate in syrup 2mg/5ml -
News MACROGOL 3350 in stick pack and jar
Treatment of chronic, accasional or medication induced constipation.Pack: stick pack & jar
Fill: 5g - 10g- 200g -
News HYALURONIC ACID in Mesotherapy
Discover Hyaluronic Acid in Pre-Filled syringes & glass vials -
News Ensiemo, the new complete child-resistant packaging solution for cbd oils
SGD Pharma today announces the launch of its new full packaging solution dedicated to the cannabidiol (CBD) oil market. Combining the company’s extensive pharmaceutical packaging expertise with the need for compliant, safe packaging for CBD oils, ... -
News Medicine to beat the papiloma virus
Procare Health makes its way into the health sector with a gel to treat and prevent a disease that affects mainly women -
News Humanigen and Lonza collaborate to expand manufacturing of COVID-19 therapeutic candidate
Humanigen's proprietary monoclonal antibody may prevent and treat cytokine storm, which is believed to trigger the acute respiratory distress syndrome in severe cases of COVID-19. -
News Univercells Technologies introduces new upstream platform for virus manufacturing
The NevoLine Upstream platform has been designed to address the needs of gene therapy and vaccine innovators and CDMOs for robust and cost-effective upstream viral vectors manufacturing. -
News Mylan and development partner win significant EPO ruling related to Copaxone
Decision clears legal pathway to expand access for patients living with multiple sclerosis in markets across Europe. -
News Fertin Pharma Issued U.S. Patent for Oral Delivery Tablet Formed by the Compression of Unique Sugar Alcohol Combinations
U.S. Patent No. 10,632,076 B2 further strengthens Fertin Pharma’s intellectual property (IP) portfolio -
News Peter Halling to become new CEO of Fertin Pharma following resignation of Søren Birn
Peter Halling has been appointed CEO of Fertin Pharma as of August 2020. -
News Evotec and Bioaster partner to build technology and innovation hub in Lyon
Together, the companies will aim to put forward new research projects against infectious diseases and antimicrobial resistance, potentially creating new therapies and technologies. -
News Biogen invests $250 million to eliminate its use of fossil fuels
After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil fuel free by 2040. -
News Annual Report preview for the CPHI Festival of Pharma
This preview from BioPlan Associates for the CPHI Festival of Pharma from 5-16 October, includes a summary of global trends and growth opportunities in biopharmaceutical product development and manufacturing and how the growth of domestic Mab pipelines... -
News Bushu Pharmaceuticals Quality Manufacturing of All Things Biotech
When western companies have established themselves in their regions, the Asian markets hold opportunities for their business expansion. In there, Japan is a one of prime targets for these expanding companies. However, launching into an unfamiliar marke... -
News Sai Life Sciences joins the ACS Green Chemistry Institute Pharmaceutical Roundtable
We have been committed to increasing the adoption of Green Chemistry principles in our process development. Joining the ACS-GCIPR will allow us to interact with large pharma and other CDMOs to further share and develop best practices in Green c... -
News Sai Life Sciences receives the 21st National Award for Excellence in Energy Management 2020
Following a string of wins over the past year, our Bidar manufacturing facility achieved another success to its credit - this time for excellence in energy management
-
News Stevanato Group Launches Robotic Human-like Inspection Unit with AI-based Machine Learning Capabilities
The Vision Robot Unit will provide biopharma companies with a fully automatized, highly accurate and flexible inspection system equipped with artificial intelligence for a variety of drug products, for increased operational efficiency. -
News Pharmapack 2021 opens entries for Patient-Centric Design Awards
The global pandemic continues to impact lots of industries and slow down business, but the pharma and packaging industries are striving to tackle new challenges to bring more faster and safer solutions to deliver medication to patients. The Pharmapack ... -
News The latest patient-centric packaging & drug delivery solutions revealed in Pharmapack 2020 Innovation Gallery
Pharmapack Europe, the leading conference & exhibition in pharma packaging & drug delivery business traded the successful 2020 edition at the beginning of February. The innovation gallery, as the key feature of this event, has gathered the most recent ... -
News What do Pharmapack Awards winners think about patient-centricity?
Pharmapack Awards winners and industry leaders will meet up in a live webinar at CPHI Festival of Pharma to discuss the evolution of next-generation products in pharma packaging, administration & drug delivery devices. -
News Sympfiny® acceptability study among young children with positive results
Scientists at the University of Birmingham, UK have evaluated Sympfiny® as device for orally dispensing multiparticulate drugs to children aged 4-12. -
News Sympfiny® showcase in OnDrugDelivery: The advantages of multiparticulate drug formulations in paediatric medicine
Multiparticulates, an emerging technology with many advantages over traditional dosage forms are particularly suited for use in paediatric medicine. The Sympfiny® system is specifically tailored to administering multiparticulate drug formulations,... -
News More than just wrapping a pill: improving patients’ lives through packaging
There is a great focus on medical packaging as a means of protecting the drug, but there is still a long way to go when talking about the real needs of patients, and what packaging can do for them. For the past six years, Giana Carli Lorenzini,Postdoct... -
News Evive Biotech Meets Primary and Secondary Endpoints in Global Phase III Clinical Trial for Their Novel Chemotherapy-induced Neutropenia Treatment
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivotal Phase III study (NCT03252431) for F-627 (efbemalenograstim alpha) to treat chemotherapy-induced neutropenia (CIN) in breast cance... -
News VAV Lipids gets written confirmation from CDSCO for Ratnagiri facility
VAV Lipids announced that it has received written confirmation for their lecithin and phospholipids manufacturing facility at Ratnagiri, India pursuant to a successful inspection carried out by Indian CDSCO. The written confirmation is required fo... -
News Mylan to acquire Aspen's thrombosis business in Europe
The transaction will further complement and expand Mylan's complex injectables offering and presence in hospitals. -
News Nippon Express to provide global pharmaceutical supply networks
The company is already constructing a digital platform for the pharmaceutical industry that will utilize IoT devices and blockchain technology to link temperature control and other logistics information end-to-end. -
News Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic
Miami, FL/June 22, 2020 - Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical ph... -
News Exelixis and Catalent collaborate to develop antibody-drug conjugates
The partnership will focus on developing multiple ADCs using Catalent’s proprietary SMARTag site-specific bioconjugation technology. -
News Key trends boosting the post-pandemic CRO market
Hybrid clinical trials leveraging safety-focused, direct-to-consumer logistical solutions are taking center stage, ensuring research continuity. -
News French cancer institute starts testing connected drug dispenser
THESS dispenser is equipped with an identity-vigilance system and warns patients when they need to take their treatment and verifies it has been delivered in accordance with the prescribed dose -
News COVID-19 ushers in age of digital, flexible EU pharmaceutical regulation
The pandemic that has swept over the world in 2020 has caused huge disruption to the European pharmaceutical industry's regulatory procedures and supply chain management. But the crisis has also provided a platform for a learning process for the sy... -
News KOLINPHARMA® expands its product portfolio with IVUXUR® TABLETS.
KOLINPHARMA® S.p.A. presents the new product IVUXUR® TABLETS, which is added to the other 9 patented or patent pending products, already present in the portfolio. -
News Bushu Pharmaceuticals Announces Major Expansion Program
Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced a major capital program costing $100 million to expand its footprint, capacity and portfolio of services. The program extends over the next ... -
News Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm
Collaboration Expedites Human Clinical Trials for COVID-19 Drug Candidate. A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today [April 28, 2020] by Quotient Sciences, a lead... -
News Gujarat, India's Pharma Hub
CPHI & P-MEC India and Global Business Reports are pleased to bring you the Gujarat Pharma 2020 report, sharing our view on the most attractive opportunities in the Indian pharma market. The report provides an outlook for the Gujarat region in India as... -
News DWK Life Sciences increases glass vial production capacity to meet demand
Best-in-class automation, robotics and state-of-the-art touchless production lines that provide the cleanliness required for parenteral packaging containers. -
News AstraZeneca's COVID-19 vaccine candidate enters Phase III trials in the US
Trial enrolling up to 30,000 adults aged 18 years or over to assess safety, efficacy and immunogenicity of AZD1222 for the prevention of COVID-19. -
News Probiotical white paper_immune defenses high definition
An effective immune system is your best defense, and the right probiotics can help! The COVID-19 global crisis has led to a peak in demand for products able to stimulate immunity. Given the well-established importance of the microbiota in immune health... -
News Biological E and GVK BIO announce strategic R&D Partnership
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and BE Pharmaceuticals Inc (BE Inc), a rapidly growing pharmaceutical company that develops, manufactures and markets complex and critical injectable products, announced a... -
News GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and Appointment of Ramesh Subramanian as its New Chief Commercial Officer
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), is pleased to announce the promotion of Sudhir Kumar Singh, Ph.D., to the position of Chief Operating Officer and the appointment of Ramesh Subramanian, Ph.D., as its new ... -
News Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development
Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of India Pvt. Ltd. (Serum), the world’s largest vaccine ma... -
News Aragen Bioscience announces the appointment of Steven Lang, PHD, MBA as Vice President, Biologics
Aragen Bioscience is pleased to announce the appointment of Dr. Steven Lang as Vice President, Biologics. Aragen, a wholly-owned subsidiary of GVK BIO, is a leading Contract Research Organization focused on accelerating biologics product development wi... -
News Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia
Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney (UTS), the top-ranked young university in Australia, are pleased to announce a collaboration to accelerate biologics R&D i... -
News Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process
Full Service “Sequence-to-Manufacturing” Offering Designed to Drive Efficiencies and Reduce Overall Timelines for Delivering Early-Stage CGMP Bulk Drug Substances -
News Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
Oragenics, Inc. (NYSE American: OGEN), (the “Company” or “Oragenics”), today announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an agreement with Aragen Bioscience, a leading contract research organization focused o... -
News KORSCH introduces next-generation mid-range tablet press
X 3 Tablet Press incorporates production capabilities and versatility traditionally limited to large-scale production machines. -
News Development of rapid novel SARS-CoV-2 diagnostics started
Enzyme specialists from EUCODIS Bioscience and diagnostics experts from Biosynth-Carbosynth have teamed up to develop a novel diagnostic tool for the fast and reliable detection of an acute SARS-CoV-2 infection. Based on viral enzymatic activities and ... -
News Managing Your Life Sciences Quality Management System Remotely
Telecommuting and online commerce has been with us for some time and works seamlessly in many industries, but the current state of events has forced companies to apply remote management to other areas that have historically been considered "hands-on" j... -
News SGS Signs Analytical Testing Agreement with AstraZeneca for COVID-19 Vaccine Candidate
SGS is pleased to announce the signing of an agreement with AstraZeneca for the provision of safety, quality control and analytical testing services in support of AZD1222 – a COVID-19 vaccine candidate co-invented by the University of Oxford and its sp... -
News SGS Joins Oxford University Consortium Led by the Jenner Institute to Develop COVID-19 Vaccine
In a consortium led by the Jenner Institute, Oxford University, SGS has joined forces with specialists in infectious diseases, research and innovation, and pharmaceuticals to rapidly develop, scale-up and produce a potential vaccine called ChAdOx1 nCov... -
News Mylan and Biocon Biologics launch Lantus biosimilar in the US
Semglee available in vial and pen presentations at a 65% discounted list price, the lowest available for a long-acting insulin glargine on the market. -
News Hovione Technology unveils collaboration for new asthma product in Turkey
Ventofor Combi Fix delivered by the PowdAir Plus dry powder inhaler. -
News Pfizer sells biologics manufacturing facility in Adelaide
Bridgewest to develop the site into a full-service contract development and manufacturing organization. -
News CPHI Webinar Series - Key Trends in Contract Manufacturing
Growing demand for pharma and biotech outsourcing presents a tremendous opportunity for CDMOs, but the impact of COVID-19 adds to a growing list of considerations for finding the right commercial partners to deliver critical medicines. A recent C... -
News Grace Doubles LUDOX® Colloidal Silica Capacity with Major European Plant Opening
June 23rd, 2020: W. R. Grace & Co., a global leader in specialty silica, today announced the opening of its new 8,200 square-meter state-of-the-art, colloidal silica plant at its European flagship manufacturing and R&D center in Worms, Germa... -
News GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.
May 08, 2019, Hyderabad, India/California, US: GVK BIO is pleased to announce the appointment of Dr. Axel Schleyer as Chief Executive Officer, Aragen Bioscience Inc. -
News LifeArc And GVK BIO Celebrate A Decade Of Partnership, Transforming Research Into Life-Saving Medicines
GVK BIO, a leading global Contract Research and Development Organisation (CRDO), and LifeArc, one of UK’s top medical research charities, are pleased to announce -
News GVK BIO Announces USFDA Approval for its cGMP Analytical Services Laboratory
GVK BIO, a leading global Contract Research and Development Organisation, announced today that United States Food and Drug Administration (FDA) has approved its cGMP Analytical Service Laboratory located at IDA, Mallapur Campus, Hyderabad. The in... -
News GVK BIO Announces Appointment of Robert R. Ruffolo, Ph.D., to its Board of Directors
GVK BIO is pleased to announce the appointment of Dr. Robert (Bob) R. Ruffolo, to its Board of Directors. -
News Diabetes, a world public health concern
Ingredia launched Pep2Dia®, specifically developed to help manage blood sugar level. This patented milk protein hydrolysate has an active dipeptide AP, which inhibits the alpha glucosidase. Preclinical and clinical studies have proven the efficacy ... -
News Connect-e-Cap®: A pillbox that pays attention
Röchling Medical's innovative intelligent packaging solution against non-adherence.
Connect-e-Cap® Reminds patients of the next required doseRecords fill level, opening time etc.Recognizes the container via pairing functionReads o... -
News WE HAVE MOVED
We are announcing a relocation... -
News Securing your end-to-end supply chain
Supply chain safety, quality and reliability are key to all our Quats and Insulin Human customers. Here is how we can help you secure your supply chain, from sourcing raw materials to delivering your products as promised – even in a global crisis. -
News Covid-19: Looking for an effective antimicrobial agent?
Benzalkonium Chloride (BKC) is recommended by several national agencies as an effective agent to control infection by Covid-19. -
News We are now certified to ISO 45001
Whether you are an employee, a manager or a business owner, we share a common goal – we don’t want anyone to get hurt on the job. Therefore, employee health and safety conditions are incorporated in all our work tasks.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance